Importance of Postprandial Glucose Control

Southern Medical Journal

Volumn 94, Issue 1-10, 2001, Pages 804-809

  Bell, David S ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

DIET RESTRICTION; FEMALE; FOOD; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; POSTPRANDIAL STATE; PREGNANCY; PREGNANCY OUTCOME; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOOD; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; POSTPRANDIAL PERIOD; PREGNANCY; PREGNANCY OUTCOME;

EID: 0035431520     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200194080-00011     Document Type: Article

References (40)

1. Jovanovic L: Rationale for prevention and treatment of postprandial glucose-mediated toxicity. Endocrinology 1999; 9:87-92
2. Avignon A, Radauceanu A, Monnier L: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997; 20:1822-1826
3. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 22(suppl 1):S5-S19
4. Poitout V, Robertson RP: An integrated view of β-cell dysfunction in type-II diabetes. Annu Rev Med 1996; 47:69-83
5. Mitrakou A, Kelley D, Mokan M, et al: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992; 326:22-29
6. Mandarino L, Baker B, Rizza R, et al: Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia 1984: 27:358-363
7. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 1990; 13:610-630
8. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47:859-866
9. Mohan V, Vijayaprabha R, Rema M: Vascular complications in long-term South Indian NIDDM of over 25 years' duration. Diabetes Res Clin Pract 1996; 31:133-140
10. Nelson RG, Tan M, Beck GJ, et al: Changing glomerular filtration with progression from impaired glucose tolerance to type II diabetes mellitus. Diabetologia 1999; 42:90-93
11. Begin E, Monticelli ML, and the Italian General Practitioner Study Group (IGPSG): Diabetic polyneuropathy in the elderly. prevalence and risk factors in two geographic areas of Italy. Acta Neurol Scan 1997: 96:223-228
12. Groot PHE, van Stiphout WAHJ, Krauss XH, et al: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991: 11:653-662
13. Patsch JR, Miesenböck G, Hopferwieser T, et al: Relation of triglyceride metabolism and coronary artery disease. studies in the postprandial state. Arterioscler Thromb 1992: 12:1336-1345
14. Bucala R, Cerami A, Vlassara H: Advanced glycosylation end products in diabetic complications. biochemical basis and prospects for therapeutic intervention. Diabetes Rev 1990; 3:258-268
15. Habib MP, Dickerson FD, Mooradian AD: Effect of diabetes, insulin, and glucose load on lipid peroxidation in the rat. Metabolism 1994; 43:1442-1445
16. Ceriello A, Quatraro A, Marchi E, et al: Impaired fibrinolytic response to increased thrombin activation in type I diabetes mellitus: effects of the glycosaminoglycan sulodexide. Diabetes Metab 1993; 19:225-229
17. Ceriello A, Falleti E, Bortolotti N, et al: Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 1996; 45:498-501
18. Donahue RP, Abbott RD, Reed DM, et al: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 1987; 36:689-692
19. Curb JD, Rodriguez BL, Burchfiel CM, et al: Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation 1995; 91:2591-2595
20. Fuller JH, Shipley MJ, Rose G, et al: Coronary-heart-disease risk and impaired glucose tolerance. the Whitehall Study. Lancet 1980; 1:1373-1376
21. Jackson CA, Yudkin JS, Forrest RD: A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. the Islington Diabetes Survey. Diabetes Res Clin Pract 1992; 17:111-123
22. Jarrett RJ, McCartney P, Keen H: The Bedford Survey: ten-year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22:79-84
23. Båvenholm P, de Faire U, Landou C, et al: Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. Eur Heart J 1998; 19:402-410
24. Håheim LL, Hohme I, Hjcnnann I, et al: Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study. Stroke 1995; 26:774-777
25. Hanefeld M, Temelkova-Kurktschiev T: The postprandial state and the risk of atherosclerosis. Diabetic Med 1997; 4(suppl 3):S6-S11
26. Beks PJ, Mackaay AJC, de Neeling JND, et al: Peripheral arterial disease in relation to glycaemic level in an elderly caucasian population: the Hoorn Study. Diabetologia 1995; 38:86-96
27. Fontbonne AM, Eschwège EM: Insulin and cardiovasculardisease. Paris Prospective Study. Diabetes Care 1991; 14:461-409
28. Pyörälä K, Savolainen E, Kaukola S, et al: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 1985; 701(suppl):38-52
29. Stolk RP, Breteler MMB, Ott A, et al: Insulin and cognitive function in an elderly population. the Rotterdam Study. Diabetes Care 1997; 20:792-795
30. Sharrett AR, Cbambless LE, Heiss G, et al, for the ARIC Investigators: Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women, the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 1995; 15:2122-2129
31. de Veciana M, Major CA, Morgan MA, et al: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333:1237-1241
32. Jovanovic-Peterson L, Peterson CM, Reed GF, et al: Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study Am J Obstet Gynecol 1991; 164:103-111
33. Combs CA, Gunderson E, Kitzmiller JL, et al: Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992; 15:1251-1257
34. Demarini S, Mimouni F, Tsang RC, et al: Impact of metabolic control of diabetes during pregnancy on neonatal hypocalcemia: a randomized study. Obstet Gynecol 1994; 83:918-922
35. American Diabetes Association: Monitoring. Medical Management of Pregnancy Complicated by Diabetes. Jovanovic L (ed). Alexandria, Va, American Diabetes Association, 2nd Ed, 1995, pp 29-38
36. Holleman F, Hoekstra JBL: Insulin lispro. N Engl J Med 1997; 337:176-183
37. Joubert PH, Venter HL, Foukaridis GN: The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism? Br J Clin Pharmacol 1990; 30:391-396
38. Schmitz O, Nyholm B, Orskov L, et al: Effects of amylin and the amylin agonist pramlintide on glucose metabolism. Diabetes Med 1997; 14(suppl 2):S19-S23
39. Wolffenbuttel BHR, Nijst L, Sels JPJE, et al: Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM. Eur J Clin Pharmacol 1993; 45:113-116
40. Bell DSH: University group diabetes program - "déjà vu all over again"? Endocr Pract 1998; 4:64-65